Bedell Frazier Investment Counseling, LLC Crispr Therapeutics Ag Transaction History

Bedell Frazier Investment Counseling, LLC

$418 Million
Q3 2024

A detailed history of Bedell Frazier Investment Counseling, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Bedell Frazier Investment Counseling, LLC holds 26,357 shares of CRSP stock, worth $1.14 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

26,357

Previous 26,139 0.83%

Holding current value

$1.14 Million

Previous $1.41 Million 12.26%

% of portfolio

0.3%

Previous 0.34%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$44.62 - $62.75 $9,727 - $13,679	218 Added 0.83%	26,357 $1.24 Million
Q2 2024 Aug 09, 2024	BUY	$51.17 - $68.18 $112,164 - $149,450	2,192 Added 9.15%	26,139 $1.41 Million
Q1 2024 May 14, 2024	SELL	$60.67 - $89.12 $1,759 - $2,584	-29 Reduced 0.12%	23,947 $1.63 Million
Q4 2023 Feb 13, 2024	SELL	$38.62 - $72.18 $23,596 - $44,101	-611 Reduced 2.49%	23,976 $1.5 Million
Q3 2023 Nov 13, 2023	BUY	$45.39 - $59.0 $8,260 - $10,738	182 Added 0.75%	24,587 $1.12 Million
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $117,282 - $182,843	-2,698 Reduced 9.95%	24,405 $1.37 Million
Q1 2023 May 09, 2023	SELL	$41.0 - $56.12 $22,919 - $31,371	-559 Reduced 2.02%	27,103 $1.23 Million
Q4 2022 Feb 09, 2023	SELL	$39.19 - $65.67 $149,117 - $249,874	-3,805 Reduced 12.09%	27,662 $1.12 Million
Q3 2022 Nov 09, 2022	SELL	$61.1 - $83.78 $178,412 - $244,637	-2,920 Reduced 8.49%	31,467 $2.06 Million
Q2 2022 Aug 03, 2022	BUY	$43.23 - $73.83 $185,110 - $316,140	4,282 Added 14.22%	34,387 $2.09 Million
Q1 2022 May 10, 2022	BUY	$53.19 - $79.24 $171,059 - $254,835	3,216 Added 11.96%	30,105 $1.89 Million
Q4 2021 Feb 09, 2022	BUY	$70.09 - $111.29 $122,096 - $193,867	1,742 Added 6.93%	26,889 $2.04 Million
Q3 2021 Nov 09, 2021	BUY	$110.2 - $156.64 $166,512 - $236,683	1,511 Added 6.39%	25,147 $2.82 Million
Q2 2021 Aug 10, 2021	BUY	$100.84 - $161.89 $69,982 - $112,351	694 Added 3.03%	23,636 $3.83 Million
Q1 2021 Apr 29, 2021	BUY	$110.72 - $210.04 $562,457 - $1.07 Million	5,080 Added 28.44%	22,942 $2.8 Million
Q4 2020 Feb 10, 2021	BUY	$79.67 - $173.23 $1.42 Million - $3.09 Million	17,862 New	17,862 $2.74 Million

Others Institutions Holding CRSP

# of Institutions

486

Shares Held

57.9M

Call Options Held

1.09M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.39B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bedell Frazier Investment Counseling, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bedell Frazier Investment Counseling, LLC with notifications on news.

Account

Bedell Frazier Investment Counseling, LLC Crispr Therapeutics Ag Transaction History